These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12646684)

  • 1. PR interval and the response to enzyme-replacement therapy for Fabry's disease.
    Waldek S
    N Engl J Med; 2003 Mar; 348(12):1186-7. PubMed ID: 12646684
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy.
    Prinz C; Farr M; Hering D; Horstkotte D; Faber L
    Clin Res Cardiol; 2010 Jan; 99(1):53-5. PubMed ID: 19774328
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme replacement therapy for Fabry's disease.
    Waldek S; Germain DP; Wanner C; Warnock DG
    Lancet; 2010 May; 375(9725):1523; author reply 1523-4. PubMed ID: 20435225
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme replacement in the treatment of Fabry's disease. Is there a point-of-no-return?
    del Toro N; Milán JA; Palma A
    Nephrol Dial Transplant; 2004 Apr; 19(4):1018. PubMed ID: 15031378
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzyme replacement therapy for Fabry's disease.
    Deegan P
    Lancet; 2010 May; 375(9725):1522-3; author reply 1523-4. PubMed ID: 20435224
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
    Mignani R; Cagnoli L
    J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.
    Spinelli L; Pisani A; Sabbatini M; Petretta M; Andreucci MV; Procaccini D; Lo Surdo N; Federico S; Cianciaruso B
    Clin Genet; 2004 Aug; 66(2):158-65. PubMed ID: 15253767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First treatment for Fabry's disease.
    FDA Consum; 2003; 37(4):4. PubMed ID: 12971327
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzyme therapy for Fabry's disease: registered for success?
    Knebelmann B; Kurschat C; Thadhani R
    Lancet; 2009 Dec; 374(9706):1950-1. PubMed ID: 19959220
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data.
    Dehout F; Schwarting A; Beck M; Mehta A; Ricci R; Widmer U;
    Acta Paediatr Suppl; 2003 Dec; 92(443):14-5; discussion 5. PubMed ID: 14989460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of replacement enzyme therapy on central nervous system manifestations in Fabry's disease].
    Besson G; Vadot W; Guellerin J
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S257-9. PubMed ID: 21211675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrazyme--recombinant protein treatment for Fabry's disease.
    Barngrover D
    J Biotechnol; 2002 May; 95(3):280-2. PubMed ID: 12080957
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme replacement therapy in patients with Fabry's disease.
    Tsuboi K
    J Int Med Res; 2007; 35(4):574-81. PubMed ID: 17697536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement in Anderson-Fabry disease.
    Bengtsson BA; Johansson JO; Hollak C; Linthorst G; FeldtRasmussen U
    Lancet; 2003 Jan; 361(9354):352. PubMed ID: 12559898
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function.
    De Schoenmakere G; Chauveau D; Grünfeld JP
    Nephrol Dial Transplant; 2003 Jan; 18(1):33-5. PubMed ID: 12480957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shire drops 'emergency' Fabry's disease drug.
    Fox JL
    Nat Biotechnol; 2012 Jun; 30(6):478. PubMed ID: 22678371
    [No Abstract]   [Full Text] [Related]  

  • 17. Do we need more intensive enzyme replacement therapy for Anderson-Fabry disease?
    Basic-Jukic N; Kes P; Mokos I; Coric M
    Med Hypotheses; 2009 Apr; 72(4):476-7. PubMed ID: 19124204
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzyme replacement in Fabry disease: the essence is in the kidney.
    Schiffmann R
    Ann Intern Med; 2007 Jan; 146(2):142-4. PubMed ID: 17179053
    [No Abstract]   [Full Text] [Related]  

  • 19. Fabry disease with special reference to neurological manifestations.
    Banerjee TK
    Eur Rev Med Pharmacol Sci; 2004; 8(6):275-81. PubMed ID: 15745387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal histology before and after effective enzyme replacement therapy in a patient with classical Fabry's disease.
    Hirashio S; Taguchi T; Naito T; Maki K; Ogata S; Taniyama K; Taniguchi Y; Yorioka N
    Clin Nephrol; 2009 May; 71(5):550-6. PubMed ID: 19473616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.